307180 — Il Science Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩70bn
- KR₩113bn
- KR₩39bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,878 | 5,798 | 8,052 | 3,080 | 10,041 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8,801 | 6,661 | 22,384 | 22,177 | 13,270 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 16,421 | 15,468 | 42,867 | 31,435 | 29,798 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10,134 | 18,802 | 24,522 | 33,121 | 35,183 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 27,215 | 40,167 | 72,860 | 72,782 | 79,398 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8,478 | 22,090 | 50,789 | 40,248 | 60,543 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 15,044 | 31,281 | 64,871 | 57,097 | 73,694 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 12,171 | 8,886 | 7,989 | 15,686 | 5,704 |
Total Liabilities & Shareholders' Equity | 27,215 | 40,167 | 72,860 | 72,782 | 79,398 |
Total Common Shares Outstanding |